- Home
- CCEP vs VTR Comparison
CCEP vs VTR Comparison
Compare CCEP & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCEP | VTR |
|---|---|---|
| Founded | 1986 | 1983 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Real Estate Investment Trusts |
| Sector | Consumer Staples | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1B | 39.0B |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CCEP | VTR |
|---|---|---|
| Price | $94.74 | $82.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $104.33 | $87.62 |
| AVG Volume (30 Days) | 1.6M | ★ 3.6M |
| Earning Date | 02-17-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.48% | 2.38% |
| EPS Growth | N/A | ★ 184.21 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $5,833,980,000.00 |
| Revenue This Year | $4.86 | $14.00 |
| Revenue Next Year | $3.79 | $8.35 |
| P/E Ratio | ★ $20.93 | $716.36 |
| Revenue Growth | N/A | ★ 18.47 |
| 52 Week Low | $84.66 | $61.76 |
| 52 Week High | $110.90 | $91.06 |
Technical Indicators
Market Signals| Indicator | CCEP | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 41.36 |
| Support Level | $89.92 | $79.53 |
| Resistance Level | $95.50 | $87.10 |
| Average True Range (ATR) | 2.11 | 2.16 |
| MACD | 0.22 | -0.95 |
| Stochastic Oscillator | 85.85 | 37.27 |
Price Performance
Historical ComparisonAbout CCEP Coca-Cola Europacific Partners plc
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.